We enable pharma teams to model drug performance using causal AI, helping reduce risk, development time, and trial failures. Discover How AI can Help You.
Learn how innovation in excipients, solvents, and patient-centric design is propelling long-acting injectables from niche therapies to the forefront of modern drug delivery.
We are a leading provider of high-quality small-molecule APIs and pharmaceutical intermediates. With over 55 years of expertise and a proven track record in developing numerous new chemical entity (NCE) products across diverse therapeutic areas, we have established ourselves as a trusted partner for innovative pharmaceutical companies worldwide.
Cellares is the first Integrated Development and Manufacturing Organization (IDMO), revolutionizing how cell therapies are mass-produced. Its flagship technologies—the Cell Shuttle™, a fully automated manufacturing unit, and Cell Q™, its quality control system—power global Smart Factories that produce 10x more therapies than CDMOs.
